Patients need to know the facts behind the Medicare GLP-1 Bridge program while considering if weight-loss drugs are right for them
Brian Wojeck, MD, MPH, Assistant Professor of Medicine (Endocrinology), Yale School of Medicine, said that because GLP-1 medications treat the primary disease of obesity, they have important effects on obesity-related comorbidities
CO 3 (Hughes 2008
Among patients with type 2 diabetes, GLP-1 use was associated with a 32% lower risk of fracture for those with osteopenia and for those with osteoporosis, as seen in Figure 1
Always dispose of your needles safely
If a tiny capillary is contacted, light bruising may occur, but this is minor and resolves without treatment